TY  - GEN
AU  - Liu,Chen-Hua
AU  - Liu,Chun-Jen
AU  - Su,Tung-Hung
AU  - Yang,Hung-Chih
AU  - Hong,Chun-Ming
AU  - Tseng,Tai-Chung
AU  - Chen,Pei-Jer
AU  - Chen,Ding-Shinn
AU  - Kao,Jia-Horng
TI  - Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
SN  - 1440-1746
PY  - 2018///0622
KW  - 2-Naphthylamine
KW  - Aged
KW  - Aged, 80 and over
KW  - Anilides
KW  - administration & dosage
KW  - Antiviral Agents
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - analogs & derivatives
KW  - Retrospective Studies
KW  - Ribavirin
KW  - Ritonavir
KW  - Safety
KW  - Sulfonamides
KW  - Taiwan
KW  - Treatment Outcome
KW  - Uracil
KW  - Valine
KW  - Viral Load
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/jgh.13912
ER  -